Ryan Beal M.d.

Ryan Beal, M.D. has a strong background in the biotech and medical industry. Ryan served as the CEO of Dyve Biosciences, a clinical stage biotech company focused on the treatment of acute gout. During their time at Dyve, Dr. Beal oversaw the completion of a Phase 2 clinical study for their lead asset, DYV700. Prior to that, they founded and served as the CEO of InSource Medical, Inc. Additionally, Dr. Beal has experience serving on the Board of Directors for the American Red Cross in the Central California Region. Ryan also founded SkinGrin.com and was a part of McKinsey & Company's Pharmaceutical and Medical Products Practice from 1999 to 2007.

Dr. Ryan Beal's education history includes a BA degree in Biophysical Chemistry and Studio Art from Dartmouth College. Ryan then pursued their MD degree at the University of Pennsylvania School of Medicine. There is no available information regarding the specific start and end years for either of these educational experiences.